Vimpat and Afinitor drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among 264 people who take Vimpat and Afinitor. Common interactions include rash among females, and pyrexia among males.
The phase IV clinical study analyzes what interactions people who take Vimpat and Afinitor have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
264 people who take Vimpat and Afinitor together, and have interactions are studied.
What is Vimpat?
Vimpat has active ingredients of lacosamide. It is used in epilepsy. Currently, eHealthMe is studying from 19,605 Vimpat users.
What is Afinitor?
Afinitor has active ingredients of everolimus. It is used in breast cancer metastatic. Currently, eHealthMe is studying from 41,006 Afinitor users.
Number of Vimpat and Afinitor reports submitted per year:
Vimpat and Afinitor drug interactions by gender *:
Vimpat and Afinitor drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Vimpat and Afinitor?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drug side effects by duration, gender and age:
Common Vimpat drug interactions:
- Vimpat and Keppra: 5,045 reports
- Vimpat and Levetiracetam: 2,524 reports
- Vimpat and Lamictal: 1,573 reports
- Vimpat and Lamotrigine: 1,131 reports
- Vimpat and Epidiolex: 1,098 reports
- Vimpat and Onfi: 1,085 reports
- Vimpat and Clonazepam: 1,010 reports
- Vimpat and Topamax: 852 reports
- Vimpat and Depakote: 835 reports
- Vimpat and Topiramate: 738 reports
Browse interactions between Vimpat and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Afinitor drug interactions:
- Afinitor and Exemestane: 3,557 reports
- Afinitor and Sandostatin: 2,514 reports
- Afinitor and Sandostatin lar: 1,895 reports
- Afinitor and Aromasin: 1,574 reports
- Afinitor and Lenvima: 1,434 reports
- Afinitor and Vitamin d: 908 reports
- Afinitor and Zometa: 895 reports
- Afinitor and Metformin: 887 reports
- Afinitor and Amlodipine: 871 reports
- Afinitor and Aspirin: 858 reports
Browse interactions between Afinitor and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on lacosamide and everolimus (the active ingredients of Vimpat and Afinitor, respectively), and Vimpat and Afinitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Vimpat and Afinitor.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cotrim and Blood Calcium Decreased - 13 seconds ago
- Allopurinol and Marrow Hyperplasia - 14 seconds ago
- Norco and Tooth Loss - 39 seconds ago
- Ipratropium Bromide and Bone Density Decreased - 41 seconds ago
- Cosopt and Alrex drug interaction - 46 seconds ago
- Diphenoxylate Hydrochloride And Atropine Sulfate and Orencia drug interaction - 58 seconds ago
- Q10 and Tinnitus Aggravated - a minute ago
- Moxifloxacin Hydrochloride and Bromhexine Hydrochloride drug interaction - a minute ago
- Antivert and Doxorubicin Hydrochloride drug interaction - a minute ago
- Monurol and Metronidazole drug interaction - a minute ago